Scientific team discovers new method to create vaccine against Chikungunya virus | Vaccine News DailyPosted: February 26, 2013
The reemergence of Chikungunya virus exemplifies the need to develop new vaccines to target other emerging viral pathogens. Chikungunya is estimated to be responsible for several million human infections in the last decade. In addition, one of its vectors, the Aedes albopictus mosquito, is moving into new regions, meaning the infection rate is expected to climb. There is currently no licensed vaccine available to use against the illness.
Another benefit of the employed strategy is that prevents the attenuated phenotype reverting by mutation or recombination, reducing the possibility that the newly created virus strain could evolve back to a pathogenic version, according to EureakAlert.com.